title: Sustained virologic response after 6 weeks of therapy with a first-generation hepatitis C virus protease inhibitor.
authors: Department of Infectious Diseases, Infection Control and Employee Health.
authors: Andreas
authors: A
authors: Kyvernitakis
authors: Elias
authors: E
authors: Jabbour
authors: Harrys A
authors: HA
authors: Torres
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; D011480:Protease Inhibitors; C486464:telaprevir